PYRROLIDINE GPR40 MODULATORS FOR THE TREATMENT OF DISEASES SUCH AS DIABETES
The present invention provides compounds of Formula (I) or a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph, or a solvate thereof, wherein all of the variables are as defined herein. These compounds are GPR40 G protein-coupled receptor modulators which may be used as medic...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French |
Published |
27.10.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides compounds of Formula (I) or a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph, or a solvate thereof, wherein all of the variables are as defined herein. These compounds are GPR40 G protein-coupled receptor modulators which may be used as medicaments.
La présente invention concerne des composés de formule (I) ou un stéréo-isomère, un tautomère, un sel pharmaceutiquement acceptable, un polymorphe ou un solvate desdits composés, toutes les variables de la formule étant telles que définies dans la description. Ces composés sont des modulateurs du récepteur couplé aux protéines G GPR40, qui peuvent être utilisés en tant que médicaments. |
---|---|
Bibliography: | Application Number: CA20152948161 |